ATE365167T1 - Aryl-substituierte benzo(d)isothiazol-3-ylamin analoga als capsaicinrezeptormodulatoren - Google Patents
Aryl-substituierte benzo(d)isothiazol-3-ylamin analoga als capsaicinrezeptormodulatorenInfo
- Publication number
- ATE365167T1 ATE365167T1 AT04786051T AT04786051T ATE365167T1 AT E365167 T1 ATE365167 T1 AT E365167T1 AT 04786051 T AT04786051 T AT 04786051T AT 04786051 T AT04786051 T AT 04786051T AT E365167 T1 ATE365167 T1 AT E365167T1
- Authority
- AT
- Austria
- Prior art keywords
- aryl
- substituted benzo
- analogas
- capsaici
- ylamin
- Prior art date
Links
- WIJQCPIRWXSWQG-UHFFFAOYSA-N 1,2-benzothiazol-3-amine Chemical class C1=CC=C2C(N)=NSC2=C1 WIJQCPIRWXSWQG-UHFFFAOYSA-N 0.000 title abstract 2
- 102000005962 receptors Human genes 0.000 abstract 3
- 108020003175 receptors Proteins 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003446 ligand Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000004913 activation Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 244000144972 livestock Species 0.000 abstract 1
- 230000004807 localization Effects 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48595803P | 2003-07-10 | 2003-07-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE365167T1 true ATE365167T1 (de) | 2007-07-15 |
Family
ID=34102670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04786051T ATE365167T1 (de) | 2003-07-10 | 2004-07-09 | Aryl-substituierte benzo(d)isothiazol-3-ylamin analoga als capsaicinrezeptormodulatoren |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20080125466A1 (de) |
| EP (1) | EP1648892B1 (de) |
| JP (1) | JP2007537978A (de) |
| CN (1) | CN1820007A (de) |
| AT (1) | ATE365167T1 (de) |
| AU (1) | AU2004259676A1 (de) |
| CA (1) | CA2531515A1 (de) |
| DE (1) | DE602004007141T2 (de) |
| ES (1) | ES2285525T3 (de) |
| WO (1) | WO2005009982A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7615570B2 (en) | 2004-12-13 | 2009-11-10 | Abbott Laboratories | Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof |
| MX2009012470A (es) * | 2007-05-18 | 2010-02-24 | Inhibox Ltd | Compuestos de acido biciclosulfonilo y su uso como agentes terapeuticos. |
| DE102022104759A1 (de) | 2022-02-28 | 2023-08-31 | SCi Kontor GmbH | Co-Kristall-Screening Verfahren, insbesondere zur Herstellung von Co-Kristallen |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5294612A (en) * | 1992-03-30 | 1994-03-15 | Sterling Winthrop Inc. | 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof |
| US6187777B1 (en) * | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
| KR100564902B1 (ko) * | 2000-08-21 | 2006-03-30 | 주식회사 태평양 | 신규 티오우레아 유도체 및 이를 함유하는 약제학적 조성물 |
| RS63204A (sr) * | 2002-01-17 | 2006-10-27 | Neurogen Corporation | Supstituisani analozi hinazolin-4-ilamina kao modulatori kapsaicina |
| AR042461A1 (es) * | 2002-12-13 | 2005-06-22 | Neurogen Corp | Analogos 2-sustituidos de quinazolin-4-il - amina. composiciones farmaceuticas |
| AU2005218655A1 (en) * | 2004-03-02 | 2005-09-15 | Neurogen Corporation | Aryl substituted purine analogues |
| EP1732560A4 (de) * | 2004-04-08 | 2010-08-18 | Neurogen Corp | Substituierte cinnolin-4-ylamine |
| TW200621251A (en) * | 2004-10-12 | 2006-07-01 | Neurogen Corp | Substituted biaryl quinolin-4-ylamine analogues |
-
2004
- 2004-07-09 CA CA002531515A patent/CA2531515A1/en not_active Abandoned
- 2004-07-09 CN CNA2004800197264A patent/CN1820007A/zh active Pending
- 2004-07-09 US US10/564,263 patent/US20080125466A1/en not_active Abandoned
- 2004-07-09 JP JP2006518907A patent/JP2007537978A/ja not_active Withdrawn
- 2004-07-09 EP EP04786051A patent/EP1648892B1/de not_active Expired - Lifetime
- 2004-07-09 WO PCT/US2004/021914 patent/WO2005009982A2/en not_active Ceased
- 2004-07-09 ES ES04786051T patent/ES2285525T3/es not_active Expired - Lifetime
- 2004-07-09 AU AU2004259676A patent/AU2004259676A1/en not_active Abandoned
- 2004-07-09 AT AT04786051T patent/ATE365167T1/de not_active IP Right Cessation
- 2004-07-09 DE DE602004007141T patent/DE602004007141T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007537978A (ja) | 2007-12-27 |
| EP1648892B1 (de) | 2007-06-20 |
| DE602004007141D1 (de) | 2007-08-02 |
| EP1648892A2 (de) | 2006-04-26 |
| WO2005009982A3 (en) | 2005-05-12 |
| ES2285525T3 (es) | 2007-11-16 |
| CA2531515A1 (en) | 2005-02-03 |
| AU2004259676A1 (en) | 2005-02-03 |
| CN1820007A (zh) | 2006-08-16 |
| DE602004007141T2 (de) | 2007-10-11 |
| WO2005009982A2 (en) | 2005-02-03 |
| US20080125466A1 (en) | 2008-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05006123A (es) | Analogos de quinazolin-4-ilamina 2-sustituida como moduladores de receptores de capsaicina. | |
| MY150731A (en) | Heteroaryl amide derivatives | |
| TW200510373A (en) | Substituted quinolin-4-ylamine analogues | |
| WO2005007648A3 (en) | Biaryl piperazinyl-pyridine analogues | |
| WO2006078992A3 (en) | Heteroaryl substituted piperazinyl-pyridine analogues | |
| PH12014501677A1 (en) | 5-membered heterocyclic amides and related compounds | |
| MY148461A (en) | Heteroaryl amide analogues as p2x7 antagonists | |
| WO2007140383A3 (en) | Spirocyclic sulfonamides and related compounds | |
| NO20043411L (no) | Substituerte quinazolin-4-ylamin analoger | |
| WO2007101007A3 (en) | Aryl sulfonyl heterocycles | |
| SG157399A1 (en) | Substituted biaryl piperazinyl-pyridine analogues | |
| WO2008024433A3 (en) | Haloalkyl-substituted pyrimidinone derivatives | |
| WO2005023807A3 (en) | 4 - heterobicyclyamino - substituted quinazolines and analogues therof as capsaicin - antagonists | |
| EA200900330A1 (ru) | Аналоги 2-феноксипиримидинона | |
| WO2008033739A3 (en) | Benzimidazole carboxamide derivatives | |
| WO2008066664A3 (en) | Cis-cyclohexyl substituted pyrimidinone derivatives | |
| WO2006076646A3 (en) | Heteroaryl substituted quinolin-4-ylamine analogues | |
| WO2006081388A3 (en) | Substituted pyridazinyl-and pyrimidinyl-quinolin-4-ylamine analogues | |
| TW200621251A (en) | Substituted biaryl quinolin-4-ylamine analogues | |
| WO2005084401A3 (en) | Aryl substituted purine analogues | |
| WO2005084368A3 (en) | Heteroalkyl-substituted biphenyl-4-carboxylic acid arylamide analogues | |
| WO2006071538A3 (en) | Substituted biaryl analogues | |
| WO2009121036A3 (en) | Substituted aryl pyrimidinone derivatives | |
| ATE365167T1 (de) | Aryl-substituierte benzo(d)isothiazol-3-ylamin analoga als capsaicinrezeptormodulatoren | |
| WO2008060568A3 (en) | Amide-substituted aryl piperidines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |